Evidence map›Paper›PMID 33886374›Full record

ReviewJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Neurotoxic Effects of Childhood Cancer Therapy and Its Potential Neurocognitive Impact.

Nicholas S Phillips, Elizabeth S Duke, Hannah-Lise T Schofield, Nicole J Ullrich

Abstract readReview
In one paragraph

Review in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Detecting High-Dose Methotrexate-Induced Brain Changes in Pediatric and Young Adult Cancer Survivors Using [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024
    Article
  12. Integrative review of school integration support following pediatric cancer.Journal of cancer survivorship : research and practice · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nicholas S PhillipsDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-2021-4036
Elizabeth S DukeCenter for Cancer and Blood Disorders, Children's National Hospital, Washington, DC.
Hannah-Lise T SchofieldDepartment of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia, PA.
Nicole J UllrichDana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA.

Funding

Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI SCOTT Loren POMEROY, MUSTAFA SAHIN · 2021 to 2026
$9.4M
Training in Pediatric Cancer Survivorship Outcomes and InterventionsT32CA225590 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Kevin R Krull · 2018 to 2026
$2.4M
NCI NIH HHS T32 CA225590NICHD NIH HHS P50 HD105351
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentChildChild, PreschoolCognitive DysfunctionFemaleHumansInfantMaleNeoplasmsNeurotoxicity Syndromes

Identifiers

PMID33886374
PMCPMC8260913

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.